Career
Current positions:
since 2004 | Director, Department of Pathology and Molecular Pathology, University Hospital Zurich, Switzerland |
---|---|
since 2004 | Full Professor of Pathology, University Zurich, Switzerland |
Education and academic experience:
2022-2023 | Medical Co-Director (ad interim), University Hospital Zurich |
---|---|
2008 – 2021 | Chairman, Operational Division of Medical Diagnostics, University Hospital Zurich, Switzerland |
08./09.2001 | Visiting Fellow. Harvard Medical School, Department of Pathology, Massachusetts General Hospital Boston, Massachusetts, USA |
1995 – 2008 | Staff (Attending Physician, Senior Attending Physician); Institute of Pathology, University Hospital Basel, Switzerland |
1994 | Research Fellow; Division of Molecular Cytometry, Department of Laboratory Medicine, University of California San Francisco; San Francisco; USA |
1990 – 1993 | Pathology Resident; Institute of Pathology, University Hospital Basel; Switzerland |
1988 – 1990 | Pathology Resident, Institute of Pathology, Charité, Berlin, Germany |
Memberships
Memberships:
2018 | WHO Classification of Tumours; 5th Edition. Editorial Board Standing Member |
---|---|
2015 | Member of the Swiss Academy of Medical Sciences |
2007 | Member of the German Academy of Science “Leopoldina” |
Patents
- 08716518.9-2406 „Monoclonal human tumor-specific antibody“ (21.10.2009)
- 08716519.7-2406 „Method of providing human tumor-specific antibodies“ (16.10.2009)
- 10162783.4-2201 „Discrete states for use as biomarkers“ (5.7.2010)
Organization of conferences
2021 | 33rd European Congress of Pathology |
---|---|
2020 | 32rd European Congress of Pathology |
2015 | WHO-Symposium “Recent Advances in Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs” |
2012 | WHO-Symposium “Recent Advances in the Pathology and Genetics of Soft Tissue and Bone Tumors” |
2012 | Leopoldina Symposium “Autopsy and Religion” |
2009 | Charles Rodolphe Brupbacher Symposium |
2007 | Charles Rodolphe Brupbacher Symposium |